Literature DB >> 24532795

Thymine DNA glycosylase is a positive regulator of Wnt signaling in colorectal cancer.

Xuehe Xu1, Tianxin Yu, Jiandang Shi, Xi Chen, Wen Zhang, Ting Lin, Zhihong Liu, Yadong Wang, Zheng Zeng, Chi Wang, Mingsong Li, Chunming Liu.   

Abstract

Wnt signaling plays an important role in colorectal cancer (CRC). Although the mechanisms of β-catenin degradation have been well studied, the mechanism by which β-catenin activates transcription is still not fully understood. While screening a panel of DNA demethylases, we found that thymine DNA glycosylase (TDG) up-regulated Wnt signaling. TDG interacts with the transcription factor TCF4 and coactivator CREB-binding protein/p300 in the Wnt pathway. Knocking down TDG by shRNAs inhibited the proliferation of CRC cells in vitro and in vivo. In CRC patients, TDG levels were significantly higher in tumor tissues than in the adjacent normal tissues. These results suggest that TDG warrants consideration as a potential biomarker for CRC and as a target for CRC treatment.

Entities:  

Keywords:  Cell Growth; Colorectal Cancer; Protein-Protein Interactions; Transcription Coactivators; Wnt Signaling

Mesh:

Substances:

Year:  2014        PMID: 24532795      PMCID: PMC3979391          DOI: 10.1074/jbc.M113.538835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability.

Authors:  Daniel Cortázar; Christophe Kunz; Jim Selfridge; Teresa Lettieri; Yusuke Saito; Eilidh MacDougall; Annika Wirz; David Schuermann; Angelika L Jacobs; Fredy Siegrist; Roland Steinacher; Josef Jiricny; Adrian Bird; Primo Schär
Journal:  Nature       Date:  2011-01-30       Impact factor: 49.962

2.  Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells.

Authors:  Jun Yang; Wen Zhang; Paul M Evans; Xi Chen; Xi He; Chunming Liu
Journal:  J Biol Chem       Date:  2006-05-03       Impact factor: 5.157

3.  Human thymine DNA glycosylase binds to apurinic sites in DNA but is displaced by human apurinic endonuclease 1.

Authors:  T R Waters; P Gallinari; J Jiricny; P F Swann
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

4.  Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.

Authors:  Sharon Amit; Ada Hatzubai; Yaara Birman; Jens S Andersen; Etti Ben-Shushan; Matthias Mann; Yinon Ben-Neriah; Irit Alkalay
Journal:  Genes Dev       Date:  2002-05-01       Impact factor: 11.361

5.  Transcriptional regulation of thymine DNA glycosylase (TDG) by the tumor suppressor protein p53.

Authors:  Nathalia Meireles da Costa; Agnès Hautefeuille; Marie-Pierre Cros; Matias Eliseo Melendez; Timothy Waters; Peter Swann; Pierre Hainaut; Luis Felipe Ribeiro Pinto
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

6.  Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer.

Authors:  Tianxin Yu; Xi Chen; Wen Zhang; Deannon Colon; Jiandang Shi; Dana Napier; Piotr Rychahou; Wange Lu; Eun Y Lee; Heidi L Weiss; B Mark Evers; Chunming Liu
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

Review 7.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

8.  The thymine-DNA glycosylase regulatory domain: residual structure and DNA binding.

Authors:  Caroline Smet-Nocca; Jean-Michel Wieruszeski; Vicky Chaar; Arnaud Leroy; Arndt Benecke
Journal:  Biochemistry       Date:  2008-06-24       Impact factor: 3.162

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

10.  SiteFind: a software tool for introducing a restriction site as a marker for successful site-directed mutagenesis.

Authors:  Paul M Evans; Chunming Liu
Journal:  BMC Mol Biol       Date:  2005-12-01       Impact factor: 2.946

View more
  14 in total

1.  miR-29b is an indicator of prognosis in breast cancer patients.

Authors:  Yoshiaki Shinden; Tomohiro Iguchi; Sayuri Akiyoshi; Hiroki Ueo; Masami Ueda; Hidenari Hirata; Shotaro Sakimura; Ryutaro Uchi; Yuki Takano; Hidetoshi Eguchi; Keishi Sugimachi; Yuko Kijima; Shoji Natsugoe; Koshi Mimori
Journal:  Mol Clin Oncol       Date:  2015-05-12

2.  E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.

Authors:  Christopher T Coey; Megan E Fitzgerald; Atanu Maiti; Katherine H Reiter; Catherine M Guzzo; Michael J Matunis; Alexander C Drohat
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

3.  DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.

Authors:  F P Fortes; H Kuasne; F A Marchi; P M Miranda; S R Rogatto; M I Achatz
Journal:  Braz J Med Biol Res       Date:  2015-04-28       Impact factor: 2.590

Review 4.  Multifaceted roles for thymine DNA glycosylase in embryonic development and human carcinogenesis.

Authors:  Xuehe Xu; David S Watt; Chunming Liu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-09-14       Impact factor: 3.848

5.  Genetic variants and risk of esophageal squamous cell carcinoma: a GWAS-based pathway analysis.

Authors:  Xi Yang; Hongcheng Zhu; Qin Qin; Yuehua Yang; Yan Yang; Hongyan Cheng; Xinchen Sun
Journal:  Gene       Date:  2014-11-26       Impact factor: 3.688

Review 6.  Roles of enhancer RNAs in sex hormone-dependent cancers.

Authors:  Lu Zhang; Xiaoxia Ye; Jieyi Luo; Jiayu Chen; Weirang Zheng; Minhua Wu
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-22       Impact factor: 4.553

7.  A germline polymorphism of thymine DNA glycosylase induces genomic instability and cellular transformation.

Authors:  Ashley Sjolund; Antonia A Nemec; Nicolas Paquet; Aishwarya Prakash; Patrick Sung; Sylvie Doublié; Joann B Sweasy
Journal:  PLoS Genet       Date:  2014-11-06       Impact factor: 5.917

8.  Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.

Authors:  Chunping Du; Nobuya Kurabe; Yoshitaka Matsushima; Masako Suzuki; Tomoaki Kahyo; Ippei Ohnishi; Fumihiko Tanioka; Shogo Tajima; Masanori Goto; Hidetaka Yamada; Hong Tao; Kazuya Shinmura; Hiroyuki Konno; Haruhiko Sugimura
Journal:  Gastric Cancer       Date:  2014-08-07       Impact factor: 7.701

9.  Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance.

Authors:  Jie Sun; Qi Shen; Haiqi Lu; Zhinong Jiang; Wenxia Xu; Lifeng Feng; Ling Li; Xian Wang; Xiujun Cai; Hongchuan Jin
Journal:  Oncotarget       Date:  2015-12-08

10.  Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization.

Authors:  Bart Kolendowski; Haider Hassan; Milica Krstic; Majdina Isovic; Gobi Thillainadesan; Ann F Chambers; Alan B Tuck; Joseph Torchia
Journal:  Epigenetics Chromatin       Date:  2018-01-29       Impact factor: 4.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.